Fear of Fall Related Factors in Chronic Stroke
3 de abril de 2022 actualizado por: Nese Olmez Sarikaya, Izmir Katip Celebi University
Relationship Between Fear of Falling and Balance, Posture, Spasticity and Functional Independence in Chronic Stroke Patients
Some stroke survivors develop a fear of falling(FoF) which may exist with or without a prior fall.
Fear of fall can be defined as decreased perceived self efficacy or confidence in maintaining balance while completing regular activities.
FoF may impair rehabilitation and recovery.
Determination of FoF related factors will help to identify interventions needed to decrease FoF.
Mostly fear of fall related factors have been studied in acute stroke patients, limited data are available for patients with chronic stroke.
The objective of this study is to evaluate frequency of FoF in chronic(>6 months) stroke patients and investigate relationship between FoF and balance, posture,spasticity and activities of daily living.
The Turkish Version of the Modified Falls Efficacy Scale was used to measure FoF.
Also a single-item dichotomous question "Are you afraid of falling?
(Yes/No)" will be asked.
Descripción general del estudio
Descripción detallada
In this observational study, chronic(>6 months) stroke patients who admitted to Physical Medicine and Rehabilitation outpatient clinic, older than 50 years old will be included.
Sociodemographic and medical data including patients' age, gender, height, weight, body mass index, contact information, marital status, educational status, plegia side, stroke etiology, time after stroke, accompanying diseases, medications used, fear of falling (yes/no), history of falling (yes/no), and the use of walking aids will be recorded.
In the evaluation of patients, Brunnstrom Hemiplegia Recovery Staging, Functional Ambulation Classification (FAC), Mini Mental State Examination(MMSE),Turkish Version of Modified Falls Efficacy Scale(MFES), Berg Balance Scale(BBS), Postural Assessment Scale for Stroke Patient Turkish Version (PASS-Turk), Modified Ashworth Scale (MAS), Modified Barthel Activities of Daily Living Index will be used.
Fear of falling will be evaluated by the same researcher using the MFES.
Also a question " Are you afraid of falling?
(Yes/No)" will be asked.
The patients will be divided into two groups as Group 1 =MFES<5 and Group2 =MFES ≥5.
Balance, posture, ambulation status, spasticity, daily living activities and Brunnstrom staging will be compared between two groups.
Correlation between MFES and balance, posture and activities of daily living will be studied.
Tipo de estudio
De observación
Inscripción (Actual)
50
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
-
İzmir, Pavo, 35150
- Izmir Katip Celebi University
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
50 años y mayores (Adulto, Adulto Mayor)
Acepta Voluntarios Saludables
No
Géneros elegibles para el estudio
Todos
Método de muestreo
Muestra de probabilidad
Población de estudio
Chronic stroke patients, admitted to Izmir Katip Celebi University Ataturk Training and Research Hospital Physical Medicine and Rehabilitation outpatient clinic, aged 50 and older.
Descripción
Inclusion Criteria:
- Patients aged 50 and over
- More than 6 months after the stroke
- Able to follow 3-digit orders
- Able to approve the consent form in writing
- Patients with a score of 23 and above on the Mini-Mental State Test will be included
Exclusion Criteria:
- Bed-dependent, wheelchair-dependent patients
- Patients diagnosed with Alzheimer's, Dementia
- Patients who are cardiovascularly unstable
- Patients with diseases that affect balance (such as Parkinson's disease, Cerebral trauma, Meniere, ear infection, Benign paroxysmal positional vertigo, Multiple sclerosis) and those who use drugs that disrupt the balance
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Fear of falling
Periodo de tiempo: 1 day (All patients will be evaluated once.)
|
Fear of falling will be measured by Turkish Version of Modified Falls Efficacy Scale(MFES).
It is a 14-question scale that evaluates patients' fear of falling and their self-confidence in performing daily living activities.
|
1 day (All patients will be evaluated once.)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Balance
Periodo de tiempo: 1 day (All patients will be evaluated once.)
|
Balance will be measured by Berg Balance Scale.
It consists of 14 sub-measurements.
Each parameter will be evaluated by scoring between 0-4 and the total score will be revealed.
Patients with a total score of 0-20 were associated with high fall risk, 21-40 moderate fall risk, 41-56 low risk
|
1 day (All patients will be evaluated once.)
|
|
Posture
Periodo de tiempo: 1 day (All patients will be evaluated once.)
|
Posture will be measured by Postural assessment scale for stroke patients (PASS-Turk).
In the scale, there are a total of 12 parameters, 5 parameters related to maintaining posture and 7 parameters related to posture change.
Each parameter will be scored between 0-3 points and the result will be the PASS-Turk Total score.
|
1 day (All patients will be evaluated once.)
|
|
Functional Independence
Periodo de tiempo: 1 day (All patients will be evaluated once.)
|
Functional independence will be measured by Modified Barthel Activities of Daily Living Index.
It is an index that evaluates the parameters of transfer, ambulation, going up and down stairs, feeding, dressing, personal care, bathing, sitting and standing on the toilet, urine continence, stool continence and collects patients in 5 groups according to these parameter scores.
In these groups evaluated between 1 and 5, 1; While it was evaluated as insufficient to do business, 5; it is evaluated completely independently.
|
1 day (All patients will be evaluated once.)
|
|
Spasticity
Periodo de tiempo: 1 day (All patients will be evaluated once.)
|
Spasticity will be measured by Modified Ashworth Scale.
The shoulder girdle, elbow, hand, hip girdle, knee and ankle-ankle joints are scored as 0/1/1 + / 2/3/4 according to the spasticity scale by evaluating the right and left sides separately with speed-dependent passive stretching.
|
1 day (All patients will be evaluated once.)
|
|
Hemiplegia stage
Periodo de tiempo: 1 day (All patients will be evaluated once.)
|
Hemiplegia stage will be measured by Brunnstrom Hemiplegia Recovery Staging.
This staging consists of 3 sub-headings: Upper extremity, Hand, and lower extremity.
Upper extremity is evaluated from stage 1 to stage 7, hand and lower extremity from stage 1 to stage 6.
|
1 day (All patients will be evaluated once.)
|
|
Ambulatory status
Periodo de tiempo: 1 day (All patients will be evaluated once.)
|
Ambulatory status will be measured by Functional Ambulation Classification.
Classification is evaluated between stage 0 and stage 5. Stage 5 refers to walking fully independently at any speed and on the ground.
|
1 day (All patients will be evaluated once.)
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Investigadores
- Silla de estudio: Nese Olmez Sarikaya, Prof, Izmir Katip Celebi University
- Investigador principal: Bekir Tetik, MD, Izmir Katip Celebi University
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
15 de enero de 2021
Finalización primaria (Actual)
1 de febrero de 2022
Finalización del estudio (Actual)
1 de febrero de 2022
Fechas de registro del estudio
Enviado por primera vez
13 de abril de 2021
Primero enviado que cumplió con los criterios de control de calidad
13 de abril de 2021
Publicado por primera vez (Actual)
14 de abril de 2021
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
5 de abril de 2022
Última actualización enviada que cumplió con los criterios de control de calidad
3 de abril de 2022
Última verificación
1 de abril de 2022
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- Fearoffallstroke
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .